Join Chamber Hill Strategies’ Melissa Bartlett for a panel discussion on CURES 2.0 Legislation and Patient-Focused Drug Development Opportunities as part of the BIO CEO & Investor Conference next week.
Registration is now open: https://bit.ly/3k2bwZJ
Melissa Bartlett, principal, presented on the changing regulatory landscape for oncologist practices at the annual meeting of the Association of Cancer Executives.
Chamber Hill Strategies is bringing on Melissa Bartlett as a principal. She was previously associate vice president for government relations at Sanofi.
Chamber Hill Strategies of the District appointed Melissa Bartlett principal.
Melissa Bartlett, a former lobbyist for Sanofi, has left the biotech company to join the lobbying firm Chamber Hill Strategies. Her résumé also includes working at Health Care Service Corporation (HCSC) and time on Capitol Hill as GOP counsel to the House Energy and Commerce Committee.